Advertisements



Alnylam confirms FDA approves Onpattro to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam"s Onpattro approved by FDA to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

FDA approves Alnylam"s Onpattro as hATTR treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic

Alnylam (ALNY) receives FDA approval for Onpattro to treat polyneuropathy of hereditary transthy.....»»

Category: dealsSource: nytAug 13th, 2018

FDA Approves $450,000-a-Year Treatment for Rare Disease

Patients who have hereditary transthyretin-mediated amyloidosis, or hATTR, will take the drug for the rest of their lives. Alnylam Phar.....»»

Category: europeSource: fortuneAug 11th, 2018

Alnylam Posts Another Encouraging Quarter Early In Onpattro"s Launch

Alnylam Posts Another Encouraging Quarter Early In Onpattro"s Launch.....»»

Category: topSource: seekingalphaMay 2nd, 2019

FDA approves marketing of L.A. company"s ADHD treatment device

The U.S. Food and Drug Administration announced it will allow the maker of the first medical device approved to treat attention deficit hyperactivity disorder (ADHD) in children to market the non-invasive treatment in the United States. The FDA .....»»

Category: topSource: bizjournalsApr 22nd, 2019

FDA approves marketing of ADHD treatment device

The U.S. Food and Drug Administration announced it will allow the maker of the first medical device approved to treat attention deficit hyperactivity disorder (ADHD) in children to market the non-invasive treatment in the United States. The FDA grant.....»»

Category: topSource: bizjournalsApr 22nd, 2019

FDA approves first generic naloxone nasal spray to treat opioid overdose

The Food.....»»

Category: topSource: marketwatchApr 19th, 2019

FDA Approves Novartis Drug To Treat More Severe Form Of Multiple Sclerosis

Culminating a month that saw mostly favorable FDA verdicts, Novartis AG (NYSE: NVS) announced regulatory approval for its multiple sclerosis drug. read more.....»»

Category: blogSource: benzingaMar 27th, 2019

FDA approves the first drug designed to treat postpartum depression

The Food and Drug Administration on Tuesda.....»»

Category: topSource: latimesMar 20th, 2019

FDA approves new treatment for postpartum depression

The FDA has approved biopharma Sage Therapeutics' first product, a drug that the company says will be the first product specifically designed to treat postpartum depression. Zulresso is Sage's (Nasdaq: SAGE) first product to reach the market and o.....»»

Category: topSource: bizjournalsMar 20th, 2019

FDA approves Sage"s first-ever treatment for postpartum depression

The FDA has approved Cambridge biopharma Sage Therapeutics' first product, a drug that the company says will be the first product specifically designed to treat postpartum depression. Zulresso is Sage's (Nasdaq: SAGE) first product to reach the market.....»»

Category: topSource: bizjournalsMar 19th, 2019

FDA approves 1st immunotherapy drug to treat breast cancer

The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer......»»

Category: topSource: foxnewsMar 8th, 2019

Alnylam confirms settlement agreement with Dicerna, will get $25M payment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2018

Young Jeff Bezos once made his grandmother burst into tears — and it taught him an important lesson on how to treat people (AMZN)

AP Images When Amazon CEO Jeff Bezos was 10 years old, he took a road trip with his grandparents that forever changed his life. During the ride, he did something that caused his grandmother to burst into tears. His gra.....»»

Category: topSource: businessinsiderMay 3rd, 2018

Europe Approves Expanded Label for Amgen Drug

The European Commission gives approval to a drug that is used to treat cardiovascular diseaseRelated Stocks: AMGN,.....»»

Category: smallbizSource: nytMay 17th, 2018

Merck confirms FDA approves Keytruda as second-line option for cervical cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Marijuana for Seizures: FDA Approves Drug Made from Pot to Treat Debilitating Epilepsy in Children

The drug, which contains CBD oil, could significantly improve the lives of child seizure sufferers who have rare forms of epilepsy......»»

Category: topSource: newsweekJun 25th, 2018

Marijuana for Seizures: FDA Approves Drug Made From Pot to Treat Debilitating Epilepsy in Children

The drug, which contains CBD oil, could significantly improve the lives of child seizure sufferers who have rare forms of epilepsy......»»

Category: topSource: newsweekJun 25th, 2018

Trump approves individual assistance for Kauai, Oahu flood victims

The Trump administration approved Hawaii Gov. David Ige’s request for individual assistance for victims of the heavy rains that caused severe flooding and landslides on Oahu and Kauai in April, after the Federal Emergency Management Agency previou.....»»

Category: topSource: bizjournalsJun 27th, 2018